169 related articles for article (PubMed ID: 37582169)
1. STICH3C: Rationale and Study Protocol.
Fremes SE; Marquis-Gravel G; Gaudino MFL; Jolicoeur EM; Bédard S; Masterson Creber R; Ruel M; Vervoort D; Wijeysundera HC; Farkouh ME; Rouleau JL;
Circ Cardiovasc Interv; 2023 Aug; 16(8):e012527. PubMed ID: 37582169
[TBL] [Abstract][Full Text] [Related]
2. Is the world ready for the STICH 3.0 trial?
Vervoort D; Jolicoeur ME; Marquis-Gravel G; Fremes SE
Curr Opin Cardiol; 2022 Nov; 37(6):474-480. PubMed ID: 36094455
[TBL] [Abstract][Full Text] [Related]
3. Left Main Coronary Artery Disease Revascularization According to the SYNTAX Score.
Shlofmitz E; Généreux P; Chen S; Dressler O; Ben-Yehuda O; Morice MC; Puskas JD; Taggart DP; Kandzari DE; Crowley A; Redfors B; Mehdipoor G; Kappetein AP; Sabik JF; Serruys PW; Stone GW
Circ Cardiovasc Interv; 2019 Sep; 12(9):e008007. PubMed ID: 31495220
[TBL] [Abstract][Full Text] [Related]
4. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
[TBL] [Abstract][Full Text] [Related]
5. Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Artery Disease: Extended Follow-Up Outcomes of Multicenter Randomized Controlled BEST Trial.
Ahn JM; Kang DY; Yun SC; Ho Hur S; Park HJ; Tresukosol D; Chol Kang W; Moon Kwon H; Rha SW; Lim DS; Jeong MH; Lee BK; Huang H; Hyo Lim Y; Ho Bae J; Ok Kim B; Kiam Ong T; Gyun Ahn S; Chung CH; Park DW; Park SJ;
Circulation; 2022 Nov; 146(21):1581-1590. PubMed ID: 36121700
[TBL] [Abstract][Full Text] [Related]
6. Long-term Outcomes in Patients With Severely Reduced Left Ventricular Ejection Fraction Undergoing Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting.
Sun LY; Gaudino M; Chen RJ; Bader Eddeen A; Ruel M
JAMA Cardiol; 2020 Jun; 5(6):631-641. PubMed ID: 32267465
[TBL] [Abstract][Full Text] [Related]
7. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199
[TBL] [Abstract][Full Text] [Related]
8. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.
Head SJ; Milojevic M; Daemen J; Ahn JM; Boersma E; Christiansen EH; Domanski MJ; Farkouh ME; Flather M; Fuster V; Hlatky MA; Holm NR; Hueb WA; Kamalesh M; Kim YH; Mäkikallio T; Mohr FW; Papageorgiou G; Park SJ; Rodriguez AE; Sabik JF; Stables RH; Stone GW; Serruys PW; Kappetein AP
J Am Coll Cardiol; 2018 Jul; 72(4):386-398. PubMed ID: 30025574
[TBL] [Abstract][Full Text] [Related]
9. Revascularization in Patients With Multivessel Coronary Artery Disease and Severe Left Ventricular Systolic Dysfunction: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.
Bangalore S; Guo Y; Samadashvili Z; Blecker S; Hannan EL
Circulation; 2016 May; 133(22):2132-40. PubMed ID: 27151532
[TBL] [Abstract][Full Text] [Related]
10. Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review.
Deb S; Wijeysundera HC; Ko DT; Tsubota H; Hill S; Fremes SE
JAMA; 2013 Nov; 310(19):2086-95. PubMed ID: 24240936
[TBL] [Abstract][Full Text] [Related]
11. Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 Trial: a comparison of fractional flow reserve-guided percutaneous coronary intervention and coronary artery bypass graft surgery in patients with multivessel coronary artery disease.
Zimmermann FM; De Bruyne B; Pijls NH; Desai M; Oldroyd KG; Park SJ; Reardon MJ; Wendler O; Woo J; Yeung AC; Fearon WF
Am Heart J; 2015 Oct; 170(4):619-626.e2. PubMed ID: 26386784
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous Left Ventricular Unloading During High-Risk Coronary Intervention: Rationale and Design of the CHIP-BCIS3 Randomized Controlled Trial.
Ryan M; Ezad SM; Webb I; O'Kane PD; Dodd M; Evans R; Laidlaw L; Khan SQ; Weerackody R; Bagnall A; Panoulas VF; Rahman H; Strange JW; Fath-Ordoubadi F; Hoole SP; Stables RH; Curzen N; Clayton T; Perera D;
Circ Cardiovasc Interv; 2024 Mar; 17(3):e013367. PubMed ID: 38410944
[TBL] [Abstract][Full Text] [Related]
13. Ten-Year Outcomes After Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Disease: Extended Follow-Up of the PRECOMBAT Trial.
Park DW; Ahn JM; Park H; Yun SC; Kang DY; Lee PH; Kim YH; Lim DS; Rha SW; Park GM; Gwon HC; Kim HS; Chae IH; Jang Y; Jeong MH; Tahk SJ; Seung KB; Park SJ;
Circulation; 2020 May; 141(18):1437-1446. PubMed ID: 32223567
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis: A Systematic Review and Meta-analysis.
Giacoppo D; Colleran R; Cassese S; Frangieh AH; Wiebe J; Joner M; Schunkert H; Kastrati A; Byrne RA
JAMA Cardiol; 2017 Oct; 2(10):1079-1088. PubMed ID: 28903139
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
[TBL] [Abstract][Full Text] [Related]
16. Impact of left ventricular ejection fraction on clinical outcomes after left main coronary artery revascularization: results from the randomized EXCEL trial.
Thuijs DJFM; Milojevic M; Stone GW; Puskas JD; Serruys PW; Sabik JF; Dressler O; Crowley A; Head SJ; Kappetein AP
Eur J Heart Fail; 2020 May; 22(5):871-879. PubMed ID: 32043709
[TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness of Percutaneous Coronary Intervention Versus Bypass Surgery for Patients With Left Main Disease: Results From the EXCEL Trial.
Magnuson EA; Chinnakondepalli K; Vilain K; Serruys PW; Sabik JF; Kappetein AP; Stone GW; Cohen DJ;
Circ Cardiovasc Interv; 2022 Jul; 15(7):e011981. PubMed ID: 35861797
[TBL] [Abstract][Full Text] [Related]
18. Predictors of long-term outcomes after bypass grafting versus drug-eluting stent implantation for left main or multivessel coronary artery disease.
Chang M; Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Han M; Park SW; Serruys PW; Park SJ
Catheter Cardiovasc Interv; 2017 Aug; 90(2):177-185. PubMed ID: 28112467
[TBL] [Abstract][Full Text] [Related]
19. Coronary revascularization for patients with severe left ventricular dysfunction.
Nagendran J; Norris CM; Graham MM; Ross DB; Macarthur RG; Kieser TM; Maitland AM; Southern D; Meyer SR;
Ann Thorac Surg; 2013 Dec; 96(6):2038-44. PubMed ID: 23968761
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with reduced ejection fraction.
Bianco V; Kilic A; Mulukutla S; Gleason TG; Kliner D; Allen CC; Habertheuer A; Aranda-Michel E; Humar R; Navid F; Wang Y; Sultan I
J Thorac Cardiovasc Surg; 2021 Mar; 161(3):1022-1031.e5. PubMed ID: 33059935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
